logo
Oncolytics Biotech® Announces Voting Results from the Annual General Meeting of Shareholders

Oncolytics Biotech® Announces Voting Results from the Annual General Meeting of Shareholders

SAN DIEGO , Aug. 11, 2025 /CNW/ -- Oncolytics Biotech ® Inc. (Nasdaq: ONCY) (TSX: ONC) ("Oncolytics" or the "Corporation" or the "Company"), a clinical-stage immunotherapy company developing pelareorep, today announced the voting results from its Annual General Meeting (AGM) of Shareholders held on Friday, August 8, 2025. A total of 37.42% of the issued and outstanding common shares of the Corporation were represented either in person or by proxy at the meeting.
On a vote by ballot, the eight nominees proposed by the Corporation were elected as Directors of Oncolytics to serve until the Corporation's next Annual Meeting of Shareholders or until their successors are elected or appointed, with shares represented at the meeting voting in favor of individual nominees as follows:
Director
For
%
Withheld
%
Patricia Andrews
10,498,328
88.83 %
1,320,714
11.17 %
Deborah M. Brown
10,115,110
85.58 %
1,703,932
14.42 %
Jared Kelly
10,830,605
91.64 %
988,437
8.36 %
Angela Holtham
10,175,887
86.10 %
1,643,155
13.90 %
James T. Parsons
10,172,958
86.07 %
1,646,084
13.93 %
Wayne Pisano
10,148,894
85.87 %
1,670,148
14.13 %
Jonathan Rigby
9,508,770
80.45 %
2,310,272
19.55 %
Bernd R. Seizinger
10,269,441
86.89 %
1,549,601
13.11 %
In addition to the election of all nominees listed as directors in the management information circular, dated June 18 , 2025, Oncolytics shareholders approved all other resolutions placed before the meeting. These included fixing the number of directors of the Corporation for the ensuing year at eight and appointing the auditors for the Corporation for the ensuing year.
For more details on the matters covered at the annual meeting, please refer to the Corporation's management information circular available on SEDAR at https://www.sedarplus.ca/home/. Final voting results on all matters voted on at the annual meeting will also be filed on SEDAR.
About Oncolytics Biotech Inc.
Oncolytics is a clinical-stage biotechnology company developing pelareorep, an intravenously delivered immunotherapeutic agent. Pelareorep has demonstrated promising results in multiple first-line pancreatic cancer studies, two randomized Phase 2 studies in metastatic breast cancer and early-phase studies in anal and colorectal cancer. It induces anti-cancer immune responses by converting immunologically "cold" tumors "hot" through the activation of innate and adaptive immune responses.
The Company is advancing pelareorep in combination with chemotherapy and/or checkpoint inhibitors in metastatic pancreatic and breast cancers, both of which have received Fast Track designation from the FDA, and other gastrointestinal tumors. Oncolytics is actively pursuing strategic partnerships to accelerate development and maximize commercial impact. For more about Oncolytics, please visit: www.oncolyticsbiotech.com or follow the Company on social media on LinkedIn and on X @ oncolytics.
Company Contact
Jon Patton
Director of IR & Communication
jpatton@oncolytics.ca
Investor Relations for Oncolytics
Mike Moyer
LifeSci Advisors
+1-617-308-4306
mmoyer@lifesciadvisors.com
Media Contact for Oncolytics
Owen Blaschak
LifeSci Communications
oblaschak@lifescicomms.com
Logo -
SOURCE Oncolytics Biotech® Inc.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Safety Shot Acquires 10% Revenue Sharing Interest in Revenue Generating BONK.fun and Appoints BONK Founding Core Members to Board
Safety Shot Acquires 10% Revenue Sharing Interest in Revenue Generating BONK.fun and Appoints BONK Founding Core Members to Board

Globe and Mail

time30 minutes ago

  • Globe and Mail

Safety Shot Acquires 10% Revenue Sharing Interest in Revenue Generating BONK.fun and Appoints BONK Founding Core Members to Board

Company Reserves "BNKK" Ticker Symbol with Nasdaq, Solidifying Full Strategic Pivot SCOTTSDALE, AZ , Aug. 12, 2025 (GLOBE NEWSWIRE) -- Safety Shot, Inc. (Nasdaq: SHOT) today announced it has acquired a 10% revenue sharing interest in the profitable launchpad, This valuable revenue sharing interest, along with an initial $25 million in BONK tokens, was the primary consideration for the preferred stock transaction announced yesterday. In a landmark move that signals a full alignment of interests, members of the BONK founding core group, including Mitchell Rudy (AKA Nom), will be appointed to the Safety Shot Board of Directors, constituting 50% of the board seats. Further solidifying its commitment to this new direction, Safety Shot also announced it has reserved the ticker symbol 'BNKK' with Nasdaq. is a decentralized platform on the Solana blockchain that allows anyone to instantly create and launch new meme coins without needing any coding expertise. It has experienced explosive growth since its launch in April 2025, rapidly becoming a dominant player in its sector. The platform is deeply integrated with the BONK ecosystem. A portion of the revenue it generates is used to buy back and burn BONK tokens on the open market. This creates constant buying pressure and reduces the supply of BONK, which is designed to increase its value and strengthen the entire ecosystem, which in turn drives more activity back to the platform. "We've built one of the most powerful, decentralized ecosystems from the ground up. Since our launch on Christmas day 2022, BONK's growth has been explosive. We have surged to a market capitalization of over $2 billion. By integrating with Safety Shot, Inc., we are creating a first-of-its-kind bridge for public market investors to directly participate in the revenue and growth of one of the most active communities in DeFi. Integrating revenue with Safety Shot will be the next step of empowering the token flywheel of BONK. This is the future of how digital assets and traditional finance will merge, and we're thrilled to build that future here', says Mitchell Rudy, one the founding core contributors of BONK.' Unlike other crypto strategies that have been announced, is different in the fact that investors will be participating in revenues generated by the platform rather than earning fees from staking. Rudy says, 'Staking offers a relatively stable, but limited, yield that is always at the mercy of the underlying token's price. The revenue share offers uncapped, exponential growth potential tied to the success of a market-leading business. It's a bet on the growth of an entire sector, not just a single asset. For Safety Shot investors, this means the Company's value is being tied to a real, high-margin, cash flow stream, which is a much more powerful and exciting proposition than simply holding tokens and hoping they go up.' In July 2025 alone, generated over $35 million in user fees. This level of profitability places it among the top 10 most profitable decentralized applications in the entire world, alongside major crypto exchanges and lending protocols, according to data from analytics platform DefiLlama. Safety Shot will reinvest approximately 90% of its revenue income from into a treasury of BONK tokens, creating a powerful growth model for the Company. BONK has solidified its position as a top meme coin globally and the mascot of the Solana blockchain. As a decentralized digital platform, operating costs are incredibly low relative to its revenue. This means as revenue grows the vast majority of that revenue can flow directly to profit, which will then be used to buy BONK tokens and add them to the treasury. The platform's activity has been immense. On peak days, it has facilitated the launch of over 20,000 new tokens in a single 24-hour period. This massive volume of new projects drives significant economic activity, with daily trading volume on the platform has exceeded $100 million. 'Today's announcements represent the next logical step in our corporate evolution,' said Jarrett Boon, CEO of Safety Shot. 'Acquiring a direct revenue stream from welcoming the visionary BONK founding core team to our board, and reserving the 'BNKK' ticker symbol are clear and deliberate actions. This strategy goes far beyond simply holding tokens; we are deeply integrating our public company with a proven, revenue-generating leader in the digital asset space. We are confident this model will unlock significant long-term value for our shareholders, following a successful blueprint that has been well-received by the market.' The constant creation of new meme coins on Solana is like a modern-day gold rush. profits by selling 'picks and shovels" to every token creator. It takes a fee from the volume of activity. Dominari Securities, LLC. is serving as the exclusive financial advisor to Safety Shot in connection with the transaction. About Safety Shot, Inc.: Safety Shot, Inc. (Nasdaq: SHOT) is a company evolving to bridge the gap between traditional public markets and the digital asset ecosystem. Following its strategic integration with the Company is executing a new strategy focused on acquiring revenue-generating assets within the DeFi space to build a robust treasury of digital assets. The Company's beverage division holds the patented Safety Shot beverage, designed to rapidly reduce blood alcohol content as well as Yerbaé's plant-based, energy beverage. About is a decentralized platform on the Solana blockchain that allows anyone to instantly create and launch new meme coins without needing any coding expertise. It has experienced explosive growth since its launch in April 2025, rapidly becoming a dominant player in its sector. Forward-Looking Statements: This press release contains forward-looking statements. All statements other than statements of historical fact are forward-looking statements, including, without limitation, statements regarding the expected completion of the acquisition. These forward-looking statements are based on the current expectations of the management of Safety Shot and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Safety Shot, Inc. undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise. Such statements are subject to risks and uncertainties, and actual results could differ materially. Factors that could cause or contribute to such differences include, but are not limited to, the performance of BONK tokens, the successful alliance and operational success with the ability to execute on the Company's treasury strategy, and other risks detailed in Safety Shot's filings with the Securities and Exchange Commission.

Billionaire Money Managers Have a Clear Favorite Artificial Intelligence (AI) Stock -- and It's Not Nvidia or Palantir
Billionaire Money Managers Have a Clear Favorite Artificial Intelligence (AI) Stock -- and It's Not Nvidia or Palantir

Globe and Mail

time33 minutes ago

  • Globe and Mail

Billionaire Money Managers Have a Clear Favorite Artificial Intelligence (AI) Stock -- and It's Not Nvidia or Palantir

Key Points Quarterly Form 13Fs provide investors with an under-the-hood look at which stocks Wall Street's brightest asset managers have been buying and selling. In spite of their outperformance, shares of Nvidia and Palantir have been sent to the chopping block by billionaire fund managers. Meanwhile, one of Wall Street's most-influential businesses finds itself as the preferred artificial intelligence (AI) stock of multiple top-tier money managers. 10 stocks we like better than Meta Platforms › For the better part of the past three years, no trend has been a bigger headline-grabber on Wall Street than the evolution of artificial intelligence (AI). Software and systems empowered with AI solutions have the ability to change the corporate growth arc in America and around the world, which is why the analysts at PwC peg this global opportunity at a jaw-dropping $15.7 trillion by 2030. But as we know from previous next-big-thing technologies, not every company will be or remain a winner. What's been particularly noteworthy about the rise of AI is how Wall Street's preeminent billionaire money managers have approached this opportunity. Based on sheer performance, graphics processing unit (GPU) colossus Nvidia (NASDAQ: NVDA) and AI-data mining specialist Palantir Technologies (NASDAQ: PLTR) have been unstoppable. Since 2023 began, shares of Nvidia and Palantir have skyrocketed by roughly 1,150% and 2,810%! However, quarterly Form 13F filings with the Securities and Exchange Commission show these two AI leaders aren't as popular as you might believe with billionaire fund managers. Instead, another market-leading business stands tall as the undisputed favorite AI stock on Wall Street. Most billionaire investors have cashed in their chips with Nvidia and Palantir A 13F allows investors to track which stocks Wall Street's smartest fund managers have been buying and selling. Coincidentally, the deadline to file 13Fs for the June-ended quarter is tomorrow, Aug. 14. Based on 13Fs from previous quarters, billionaires have spoken loudly with their actions. Both Stanley Druckenmiller of Duquesne Family Office and Stephen Mandel of Lone Pine Capital completely exited their respective stakes in Nvidia, while billionaires David Tepper of Appaloosa and Philippe Laffont of Coatue Management disposed of the bulk of their shares. It's a similar story for Palantir, with Druckenmiller sending all of his fund's shares to the chopping block. Although both companies have exhibited phenomenal sales and profit growth, there are a couple of well-defined reasons for billionaire fund managers to be skeptical. Arguably the biggest worry with the AI revolution is that history will repeat itself. Including the rise and proliferation of the internet, there hasn't been a game-changing innovation in over three decades that's avoided an early innings bubble-bursting event. Without fail, investors consistently overestimate the early stage utility and consumer/enterprise adoption of new technologies, which eventually leads to lofty expectations not being met. If an AI bubble were to form and burst, it would be terrible news for Nvidia and Palantir. The other historical overhang for Nvidia and Palantir is their respective premium valuations. Though Nvidia's forward price-to-earnings (P/E) ratio isn't egregiously high, its trailing-12-month price-to-sales (P/S) ratio of more than 30 is in-line with other cutting-edge businesses that peaked during the dot-com era. Palantir's premium is considerably higher than Nvidia's. Whereas most industry leaders top out at P/S ratios of 30 to 40, Palantir is tipping the scales at a P/S ratio of 137, as of the closing bell on Aug. 8. No megacap company has ever been able to sustain a premium of this magnitude, and Palantir, despite its irreplaceable Gotham and Foundry platforms, is unlikely to be the exception to this unwritten rule. While billionaire fund managers have been content to reduce or remove Nvidia and Palantir stock from their portfolios, there's another industry-leading AI stock they're all in on. This is the undisputed favorite AI stock of billionaire money managers Among the dozens upon dozens of companies making AI a cornerstone of their future growth plans, none has been more sought after by billionaire investors than Meta Platforms (NASDAQ: META). Based on 13Fs filed in mid-May for trading activity that concluded March 31, four billionaire asset managers listed Meta as their fund's top holding: Chase Coleman of Tiger Global Management: 16.18% of invested assets. Terry Smith of Fundsmith: 10.19% of invested assets. Philippe Laffont of Coatue Management: 9.55% of invested assets. Stephen Mandel of Lone Pine Capital: 8.75% of invested assets. In addition to being the No. 1 holding for four prominent fund managers, it's the third largest position, excluding put and call options, for Israel Englander of Millennium Management, the No. 6 holding for Steven Cohen's Point72 Asset Management (also excluding options), and the 10th biggest holding for Ken Fisher of Fisher Asset Management. In other words, there's no doubt whatsoever that Meta Platforms is the clear favorite AI stock of billionaire investors. The interesting quirk about Meta is that, for the moment, it's almost exclusively an advertising-driven company. Through the first six months of 2025, just shy of 98% of its $89.8 billion in sales traced back to advertising on the company's social media sites, which include Facebook, Instagram, WhatsApp, Threads, and Facebook Messenger. No social media company comes remotely close to the 3.48 billion daily active people Meta attracted to its family of apps in June. Businesses are willing to pay a premium to get their message(s) in front of users, and there's no better platform to do that with than Meta. But advertising is also where artificial intelligence is laying its roots for Meta. Integrating generative AI solutions into its advertising platform is allowing businesses to tailor and create messages for specific users, with the ultimate goal of improving click-through rate. The fact that Meta Platforms absolutely blew Wall Street's consensus revenue forecast out of the water during the June-ended quarter is an indication that its investments in AI are paying off. Looking a bit further down the line, Meta Platforms CEO Mark Zuckerberg aims to use AI as a tool to monetize the metaverse -- the 3D virtual world where users can interact with each other and their environment. Meta is positioning itself to be an on-ramp to the metaverse, and Zuckerberg has a lengthy track record of slow-stepping the monetization of new products and services until the time is right. Another factor that's helping Meta succeed, and which may be coercing billionaire fund managers to pile in, is the company's enormous cash pile. It closed out the June quarter with a little over $47 billion in cash, cash equivalents, and marketable securities, and is pacing nearly $100 billion in net cash generation from operating activities for the full year. A sizable treasure chest allows Meta to take risks that few other companies can afford to. Lastly, Meta's valuation remains reasonable. Even though its forward P/E of 25.8 is 22% above its average forward P/E over the trailing-five-year period, Meta has consistently blown past consensus earnings estimates and looks to maintain an annual sales growth rate of 15% or greater for the foreseeable future. Should you invest $1,000 in Meta Platforms right now? Before you buy stock in Meta Platforms, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Meta Platforms wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $653,427!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,119,863!* Now, it's worth noting Stock Advisor's total average return is 1,060% — a market-crushing outperformance compared to 182% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of August 11, 2025

Elon Musk says he plans to sue Apple for not featuring X or Grok as top apps
Elon Musk says he plans to sue Apple for not featuring X or Grok as top apps

Globe and Mail

time2 hours ago

  • Globe and Mail

Elon Musk says he plans to sue Apple for not featuring X or Grok as top apps

Billionaire SpaceX, Tesla TSLA-Q and X owner Elon Musk says he plans to sue Apple AAPL-Q for not featuring X and its Grok artificial intelligence chatbot app in its top recommended apps in its App Store. Musk posted the comments on X late Monday, saying, 'Hey @Apple App Store, why do you refuse to put either X or Grok in your 'Must Have' section when X is the #1 news app in the world and Grok is #5 among all apps? Are you playing politics? What gives? Inquiring minds want to know.' Grok is owned by Musk's artificial intelligence startup xAI. Tesla to streamline AI chip research, Musk says, after report supercomputer team being disbanded Musk went on to say, 'Apple is behaving in a manner that makes it impossible for any AI company besides OpenAI to reach #1 in the App Store, which is an unequivocal antitrust violation. xAI will take immediate legal action.' He gave no further details. In an e-mailed statement, Apple defended the fairness of its App Store. 'The App Store is designed to be fair and free of bias,' it said. 'We feature thousands of apps through charts, algorithmic recommendations, and curated lists selected by experts using objective criteria. Our goal is to offer safe discovery for users and valuable opportunities for developers, collaborating with many to increase app visibility in rapidly evolving categories.' The company has faced various allegations of antitrust violations in recent years. A federal judge recently found that Apple violated a court injunction in an antitrust case filed by Fortnite maker Epic Games. Regulators of the 27-nation European Union fined Apple €500-million ($805-million) in April for breaking competition rules by preventing app makers from pointing users to cheaper options outside its App Store. Last year, the EU fined the U.S. tech giant nearly US$2-billion for unfairly favouring its own music streaming service by forbidding rivals like Spotify from telling users how they could pay for cheaper subscriptions outside of iPhone apps. As of early Tuesday, the top app in Apple's App Store was TikTok, followed by Tinder, Duolingo, YouTube and Bumble. Open AI's ChatGPT was ranked 7th.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store